Patient Safety Perspective

 
 
  • NPs and Physicians: The Changing Scope of Practice Nurse practitioners (NPs) discuss their evolving professional relationships with physicians and shifting boundaries in practice responsibilities.
  • EASD 2022 New Studies Change Beliefs About Cardiovascular Disease   From timing of medications to supplement use, Dr Anne Peters reviews several recent studies that have changed beliefs in the realm of cardiovascular disease.
  • The Surprising Failure of Vitamin D in Deficient Kids   Another vitamin D supplementation trial fails to impress, this time in kids with low levels. F. Perry Wilson argues that a new approach might be needed.
  • 5 Things to Know About This Early Flu Season In the past 2 years there was relatively little flu activity, but this time the US is experiencing an early and potentially harsh flu season.
  • Alcohol, Melatonin, and Other Top Clinical Topics of 2022 See which studies led to the most popular clinical topics of the year, with an infographic on each of the key findings.
  • 'First Step' Toward Delaying Progression of Type 1 Diabetes   Dr Anne Peters discusses the approval of teplizumab and its potential impact in delaying the onset of stage 3 diabetes for patients age 8 years or older who currently have stage 2 type 1 diabetes.
  • Starting Lamotrigine: Who Needs an EKG?   Drs Wilner and French discuss the latest FDA label changes on lamotrigine and what they mean in practice.
  • Are Joint Commission Safety Rules Really Backed by Evidence?   Dr Alok Patel discusses the Joint Commission and the associated requirements for accreditation.
  • Percutaneous LAA Closure in Patients With AF   What considerations are involved in percutaneous LAA closure in stroke risk management for patients with AF? Drs Ashish Bhimani and Sandeep Goyal examine the evidence.
  • AHA 2022 STRONG-HF Strategy for Intense ADHF Discharge Care Explained   Alexandre Mebazaa gives Ileana Piña the details on the STRONG-HF trial that showed benefits for early intensive drug therapy after hospitalization for acute decompensated heart failure.
  • AHA 2022 Meds and Community Over Mindfulness for Most Hypertension   Catch up on blood pressure presentations from the 2022 American Heart Association meeting, including ones on mindfulness, community approaches, and a comparison of hydrochlorothiazide and chlorthalidone.
  • IDWeek 2022 IDWeek 2022: COVID News for Clinical Practice or FDA Consideration   Paul Auwaerter, MD, discusses results from abstracts presented at IDWeek 2022 related to COVID-19 that may be interesting for clinical practice or may appear in front of the FDA soon.
  • How Can I Keep From Losing My Mind? Douglas A. Paauw, MD, discusses how patients can exercise their brains to prevent dementia.
  • Bugs, Drugs, and the Placenta Experts discuss the mechanisms that the body has in place for protection, such as the blood-brain barrier and the placenta.
  • Heart Supplements Flunk Lipid Lowering Test: SPORT Interview   Luke Laffin, MD, provides details on the SPORT trial which compared low-dose rosuvastatin with six over-the-counter supplements, including fish oils, turmeric, garlic, and plant sterols.
  • Paxlovid and Long COVID A new VA study adds a third way of reducing Long COVID, no less important complications across multiple organ systems, and improved survival and avoidance of hospitalizations. It is the first such report.
  • Which mRNA Vaccine Poses a Lower Risk for Myocarditis?   Dr F. Perry Wilson comments on a study that compared myocarditis rates following Pfizer and Moderna COVID vaccines.
  • Infographic: Where Physicians Side on Difficult Choices Doctors reveal how they would react to four ethically challenging scenarios that could involve the quality of patient treatment or patient interactions.
  • Nov 4 2022 This Week in Cardiology   AF conversion in the ED, HRT, a shining example of evidence-based medicine and less-is-more, multimorbidity, and what’s coming at AHA are the topics John Mandrola, MD, covers in this week’s podcast.
  • Regenerative Medicine Landscape Continues to Evolve Dr Kathleen Davenport describes how platelet-rich plasma and stem-cell injections are currently used for tendinopathies and arthritis and what to watch for in the widely varying protocols being used.